You are here: Industry Insights > mRNA

News List

Touchlight and GSK Sign License Agreement for Use of Enzymatic dbDNA Production Technology for mRNA Manufacturing Biotech Newswire
July 24, 2024
Touchlight announced a license agreement with GSK, a global leader in biopharmaceutical innovation.
Is mRNA Vaccine the Source of Intricacies of "Mysterious Hepatitis"? PharmaSources/Yefenghong
May 23, 2022
3 years into the COVID-19 pandemic, it has had a significant impact on human health and economic development. Based on WHO statistics, as of April 22, there are approximately 497 million confirmed patients and 6.179 million deaths in the world because of
Supported by Capital, the Application of mRNA Technology has Become a Hot Field in China PharmaSources/Xiaoyaowan
December 17, 2021
In the middle of August, Abogen Biosciences announced that it had completed a third round of financing with its total amount exceeding 700 million US dollars, which set a new record for single financing before IPO of Chinese biopharmaceutical companies.
Designing the Messenger: Story of the mRNA Vaccine Neeta Ratanghayra
November 05, 2020
In early January this year, Chinese authorities shared the genetic sequence of SARS-CoV-2, the novel coronavirus.
Inactivated Virus Vaccines vs. mRNA Vaccines: Differences between China and the U.S. in Preferred Technologies for Developing COVID-19 Vaccines PharmaSources/Xiaoyaowan
November 13, 2020
The cumulative number of confirmed cases of COVID-19 has exceeded 11.30 million worldwide by July 5. The vaccine development has been in full swing in each country since the occurrence of the virus.
AIM Vaccine's mRNA Shingles Vaccine Submits Clinical Application to the U.S. PR Newswire
February 25, 2025
Another Step Forward in Global Expansion
Dx&Vx, From mRNA Vaccines to Nanoparticle Vaccines era of Next-Generation Vaccines PRNewswire
January 08, 2025
The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies.
Recbio Provides Updates on First Lyophilized mRNA Vaccine and Pre-clinical Data Showing Long-term stability and Strong immunogenicity against SARS-CoV-2 prnasia
February 15, 2022
Jiangsu Recbio Technology Co., Ltd. (Recbio), a China-based company focused on the development of innovative vaccines for major diseases, announced preclinical data...
First study to show waning effectiveness of 3rd dose of mRNA vaccines WorldPharmaNews
February 14, 2022
A nationwide study from the U.S. Centers for Disease Control and Prevention (CDC) is the first to show that immunity against severe COVID-19 disease begins to wane 4 months after receipt of the third dose of an mRNA vaccine (Pfizer or Moderna).
Celartics Biopharma announces a new generation mRNA vaccine against COVID-19 FirstWordPharma
February 14, 2022
Celartics Biopharma today announced that they have achieved major milestones and encouraging results in developing a new generation of mRNA vaccine, CA-R03, designed to prevent infection from SARS-COV-2 virus.